全文获取类型
收费全文 | 1930篇 |
免费 | 156篇 |
国内免费 | 12篇 |
专业分类
耳鼻咽喉 | 8篇 |
儿科学 | 134篇 |
妇产科学 | 38篇 |
基础医学 | 175篇 |
口腔科学 | 72篇 |
临床医学 | 260篇 |
内科学 | 344篇 |
皮肤病学 | 30篇 |
神经病学 | 103篇 |
特种医学 | 239篇 |
外科学 | 218篇 |
综合类 | 57篇 |
预防医学 | 112篇 |
眼科学 | 61篇 |
药学 | 111篇 |
1篇 | |
中国医学 | 2篇 |
肿瘤学 | 133篇 |
出版年
2021年 | 19篇 |
2020年 | 9篇 |
2019年 | 15篇 |
2018年 | 33篇 |
2017年 | 18篇 |
2016年 | 14篇 |
2015年 | 30篇 |
2014年 | 36篇 |
2013年 | 44篇 |
2012年 | 63篇 |
2011年 | 73篇 |
2010年 | 66篇 |
2009年 | 72篇 |
2008年 | 77篇 |
2007年 | 41篇 |
2006年 | 49篇 |
2005年 | 64篇 |
2004年 | 52篇 |
2003年 | 53篇 |
2002年 | 58篇 |
2001年 | 25篇 |
2000年 | 27篇 |
1999年 | 36篇 |
1998年 | 93篇 |
1997年 | 95篇 |
1996年 | 100篇 |
1995年 | 74篇 |
1994年 | 58篇 |
1993年 | 52篇 |
1992年 | 31篇 |
1991年 | 33篇 |
1990年 | 32篇 |
1989年 | 44篇 |
1988年 | 40篇 |
1987年 | 63篇 |
1986年 | 30篇 |
1985年 | 37篇 |
1984年 | 30篇 |
1983年 | 29篇 |
1982年 | 30篇 |
1981年 | 27篇 |
1980年 | 21篇 |
1979年 | 15篇 |
1978年 | 11篇 |
1977年 | 24篇 |
1976年 | 25篇 |
1975年 | 16篇 |
1974年 | 9篇 |
1967年 | 9篇 |
1964年 | 7篇 |
排序方式: 共有2098条查询结果,搜索用时 0 毫秒
41.
42.
Barrie J. Hurwitz 《Annals of Indian Academy of Neurology》2009,12(4):226-230
The diagnosis of multiple sclerosis (MS) requires objective findings referable to the central nervous system. A wide differential diagnosis often has to be considered. Magnetic resonance imaging and electrophysiologic and cerebrospinal fluid studies can all contribute to an early definitive diagnosis. The McDonald diagnostic criteria for MS (2005) are the currently recognized MS diagnostic criteria. The clinical subtypes of MS and their diagnosis are discussed in this article. Being informed of the diagnosis may be a stressful experience for the patient and this is also dealt with. 相似文献
43.
Recombinant adeno-associated virus serotype 2 (rAAV2)-based human gene therapy for cystic fibrosis has progressed through a series of preclinical studies and phase I and II clinical trials. This agent has shown an encouraging safety profile, consistent levels of DNA transfer, and positive evidence of short-term clinical improvement in lung function in a prospective, placebo-controlled phase II trial of aerosol administration. Nonetheless, it has been difficult to assess the relationship between its molecular action and the observed clinical improvements, because of the lack of positive results from a highly specific assay for vector mRNA. This issue is further complicated by the fact that the clinical vector utilizes a small cryptic rAAV2 promoter sequence that is less robust for mRNA expression than typical viral promoters. In this paper, we report the results of more sensitive assays performed on primary nasal cells harvested from rAAV2-CFTR gene therapy recipients. These studies demonstrate a correlation between the presence of rAAV2-CFTR vector genomes, CFTR mRNA expression, and cAMP-activated chloride channel function in these cells. The observation of sizeable physiological correction in the face of low mRNA levels may reflect the regulatory role of low levels of CFTR protein as an activator of other chloride channels. 相似文献
44.
In order to study the pattern of B cell involvement in acute nonlymphocytic leukemia (ANLL), multiple B lymphoid cell lines were established by Epstein-Barr virus transformation of peripheral blood mononuclear cells from two patients with the disease who were heterozygous for the X chromosome-linked glucose-6-phosphate dehydrogenase (G6PD). In one patient, the progenitor cells involved by the leukemia exhibited multipotent differentiative expression, whereas in the other patient the cells showed differentiative expression restricted to the granulocytic pathway. In the patient whose abnormal clone showed multipotent expression, the ratio of B-A G6PD in B lymphoid cell lines was skewed in the direction of type B (the enzyme characteristic of the leukemia clone) and significantly different from the 1:1 ratio expected. It is, therefore, likely that the neoplastic event occurred in a stem cell common to the lymphoid series as well as to the myeloid series. In contrast, evidence for B cell involvement was not detected in the patient whose ANLL progenitor cells exhibited restricted differentiative expression. These findings underscore the heterogeneity of ANLL. Clinically and morphologically similar malignancies in these two patients originated in progenitors with different patterns of stem cell differentiative expression. This difference may reflect differences in cause and pathogenesis. 相似文献
45.
Hendrickx J; Dams E; Coucke P; Lee P; Fernandes J; Willems PJ 《Human molecular genetics》1996,5(5):649-652
X-linked liver glycogenosis type II (XLG II) is a recently described X-
linked liver glycogen storage disease, mainly characterized by enlarged
liver and growth retardation. These clinical symptoms are very similar to
those of XLG I. In contrast to XLG I patients, however, XLG II patients do
not show an in vitro enzymatic deficiency of phosphorylase kinase (PHK).
Recently, mutations were identified in the gene encoding the liver alpha
subunit of PHK (PHKA2) in XLG I patients. We have now studied the PHKA2
gene of four unrelated XLG II patients and identified four different
mutations in the open reading frame, including a deletion of three
nucleotides, an insertion of six nucleotides and two missense mutations.
These results indicate that XLG II is due to mutations in PHKA2. In
contrast to XLG I, XLG II is caused by mutations that lead to minor
structural abnormalities in the primary structure of the liver alpha
subunit of PHK. These mutations are found in a conserved RXX(X)T motif,
resembling known phosphorylation sites that might be involved in the
regulation of PHK. These findings might explain why the in vitro PHK
enzymatic activity is not deficient in XLG II, whereas it is in XLG I.
相似文献
46.
47.
48.
49.
50.